KILITCH — Kilitch Drugs (India) Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹6.52bn
- IN₹6.41bn
- IN₹1.98bn
- 57
- 31
- 83
- 62
Annual cashflow statement for Kilitch Drugs (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 51.2 | 96.1 | 120 | 194 | 345 |
| Depreciation | |||||
| Non-Cash Items | 8.13 | 14.3 | 62.4 | 85 | -19.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 377 | -77.3 | -192 | -313 | -181 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 457 | 57.8 | 25.9 | -1.46 | 175 |
| Capital Expenditures | -363 | -82 | -38.1 | -64.5 | -469 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -12.7 | -70.5 | 117 | -30.9 | 69.3 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -376 | -153 | 79.2 | -95.4 | -399 |
| Financing Cash Flow Items | -6.41 | 56.4 | -49.8 | -45 | -45.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.1 | 70.3 | -7.16 | 88.1 | 132 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 97 | -24.4 | 97.8 | -8.84 | -91.6 |